|
| 36259569 | Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer. | Asian J Androl | 2023 |
| 37629142 | Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro. | Int J Mol Sci | 2023 |
| 37627171 | Editorial: The Application of Proteogenomics to Urine Analysis for the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. | Cancers (Basel) | 2023 |
| 37424308 | Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non-Indigenous men in a universal health care system. | Cancer | 2023 |
| 37345203 | Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer. | Cancers (Basel) | 2023 |
| 37047027 | <i>Downregulation of BUD31</i> Promotes Prostate Cancer Cell Proliferation and Migration via Activation of p-AKT and Vimentin In Vitro. | Int J Mol Sci | 2023 |
| 37370778 | Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations. | Cancers (Basel) | 2023 |
| 36901698 | Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro. | Int J Mol Sci | 2023 |
| 35982181 | Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer. | J Cancer Res Clin Oncol | 2023 |
| 34643090 | Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy. | J Urol | 2022 |
| 35563163 | The Expression of Proto-Oncogene <i>ETS-Related Gene</i> (<i>ERG</i>) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer. | Int J Mol Sci | 2022 |
| 36362115 | The Association between Cyclin Dependent Kinase 2 Associated Protein 1 (CDK2AP1) and Molecular Subtypes of Lethal Prostate Cancer. | Int J Mol Sci | 2022 |
| 35163398 | ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro. | Int J Mol Sci | 2022 |
| 33398501 | [Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]. | Pathologe | 2021 |
| 33771697 | Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein by Orthogonal Immunoprecipitation-Mass Spectrometry Assays. | Mol Cell Proteomics | 2021 |
| 33864110 | Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation. | J Cancer Res Clin Oncol | 2021 |
| 34068856 | Copy Number Profiles of Prostate Cancer in Men of Middle Eastern Ancestry. | Cancers (Basel) | 2021 |
| 34337539 | Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease. | Eur Urol Open Sci | 2021 |
| 31455846 | Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance. | Prostate Cancer Prostatic Dis | 2020 |
| 35050780 | Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate. | JCO Precis Oncol | 2020 |
| 34337483 | High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival. | Eur Urol Open Sci | 2020 |
| 31812633 | Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy. | Urol Oncol | 2020 |
| 32044806 | Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer. | Am J Surg Pathol | 2020 |
| 32576165 | DNA methylation signatures of Prostate Cancer in peripheral T-cells. | BMC Cancer | 2020 |
| 32520708 | Case - Highly aggressive urothelial carcinoma of the bladder presenting with solitary metastasis to the phalanx. | Can Urol Assoc J | 2020 |
| 32238875 | Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization. | Mod Pathol | 2020 |
| 32350606 | Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication. | J Cancer Res Clin Oncol | 2020 |
| 31584209 | Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue. | Prostate | 2020 |
| 30542054 | Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance. | Prostate Cancer Prostatic Dis | 2019 |
| 31206668 | Development of a predictive model for stromal content in prostate cancer samples to improve signature performance. | J Pathol | 2019 |
| 31129769 | Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer. | J Cancer Res Clin Oncol | 2019 |
| 31125117 | Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma. | Int J Cancer | 2019 |
| 29511883 | Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer. | J Cancer Res Clin Oncol | 2018 |
| 30165429 | Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. | Carcinogenesis | 2018 |
| 30101374 | Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification. | J Cancer Res Clin Oncol | 2018 |
| 29904055 | Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis. | Nat Commun | 2018 |
| 27738792 | SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion. | Pathol Oncol Res | 2017 |
| 28265591 | Tubulovillous Adenoma in the Bladder in a Dual Pancreas-Kidney Transplant Patient. | J Endourol Case Rep | 2017 |
| 28511652 | ING3 promotes prostate cancer growth by activating the androgen receptor. | BMC Med | 2017 |
| 28786877 | Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity. | Am J Surg Pathol | 2017 |
| 26725250 | SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development. | Urol Oncol | 2016 |
| 27819326 | Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2. | Sci Rep | 2016 |
| 27271990 | High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer. | Tumour Biol | 2016 |
| 27534968 | Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients. | J Mol Med (Berl) | 2016 |
| 26803516 | ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients. | Tumour Biol | 2016 |
| 26711283 | ERG expression in prostate cancer: biological relevance and clinical implication. | J Cancer Res Clin Oncol | 2016 |
| 26907180 | microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. | Mol Biol Rep | 2016 |
| 26795349 | Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer. | Cancer Res | 2016 |
| 25517865 | ERG Expression in Prostate Needle Biopsy: Potential Diagnostic and Prognostic Implications. | Appl Immunohistochem Mol Morphol | 2015 |
| 25819753 | ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal. | Eur J Cell Biol | 2015 |